• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erythropoiesis-stimulating agents--time for a reevaluation.

作者信息

Unger Ellis F, Thompson Aliza M, Blank Melanie J, Temple Robert

机构信息

Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.

出版信息

N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6.

DOI:10.1056/NEJMp0912328
PMID:20054037
Abstract
摘要

相似文献

1
Erythropoiesis-stimulating agents--time for a reevaluation.促红细胞生成素——是时候重新评估了。
N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6.
2
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).重新审视贫血治疗证据的时机（TREAT）=基本安全论据（ESA）。
Nephrol Dial Transplant. 2010 Jun;25(6):1734-7. doi: 10.1093/ndt/gfq099. Epub 2010 Mar 2.
3
Treatment of anemia in chronic kidney disease--strategies based on evidence.慢性肾脏病贫血的治疗——基于证据的策略
N Engl J Med. 2009 Nov 19;361(21):2089-90. doi: 10.1056/NEJMe0909664. Epub 2009 Oct 30.
4
Darbepoetin alfa and chronic kidney disease.达比泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654; author reply 655.
5
An ongoing study of anemia correction in chronic kidney disease.一项正在进行的慢性肾脏病贫血纠正研究。
N Engl J Med. 2007 Mar 1;356(9):959-61. doi: 10.1056/NEJMc066568.
6
Darbepoetin alfa and chronic kidney disease.达贝泊汀α与慢性肾脏病
N Engl J Med. 2010 Feb 18;362(7):654-5; author reply 655.
7
Emerging drugs for treatment of anemia of chronic kidney disease.新兴药物治疗慢性肾脏病相关性贫血。
Expert Opin Emerg Drugs. 2013 Dec;18(4):421-9. doi: 10.1517/14728214.2013.836490. Epub 2013 Sep 16.
8
Does TREAT give the boot to ESAs in the treatment of CKD anemia?在慢性肾脏病贫血的治疗中，TREAT是否会淘汰促红细胞生成素类药物？
J Am Soc Nephrol. 2010 Jan;21(1):2-6. doi: 10.1681/ASN.2009111127. Epub 2009 Dec 24.
9
Chronic kidney disease anemia management: what should be done?慢性肾脏病贫血管理：应该怎么做？
Blood Purif. 2011;31(1-3):186-8. doi: 10.1159/000321852. Epub 2011 Jan 10.
10
Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease.聚乙二醇化促红细胞生成素α治疗慢性肾脏病贫血的药物安全性概况
Expert Opin Drug Saf. 2009 Mar;8(2):145-53. doi: 10.1517/14740330902793031.

引用本文的文献

1
The Efficacy and Safety of a Personalized Protocol Designed to Balance Hemoglobin Levels in Hemodialysis Patients as Led by Nephrology Clinical Nurse Specialists: An Intervention Study.由肾脏病临床护理专家主导的旨在平衡血液透析患者血红蛋白水平的个性化方案的疗效与安全性：一项干预性研究。
Healthcare (Basel). 2025 Jun 2;13(11):1317. doi: 10.3390/healthcare13111317.
2
Comprehensive Strategies for Preoperative Pulmonary Risk Evaluation and Management.术前肺风险评估与管理的综合策略
Tuberc Respir Dis (Seoul). 2025 Jan;88(1):90-108. doi: 10.4046/trd.2024.0118. Epub 2024 Oct 30.
3
Roxadustat for Treating Anemia in Patients with Advanced Chronic Kidney Disease Not Undergoing Dialysis: A Retrospective Study.
罗沙司他治疗未接受透析的晚期慢性肾脏病患者贫血的回顾性研究。
Intern Med. 2025 May 1;64(9):1303-1314. doi: 10.2169/internalmedicine.3773-24. Epub 2024 Oct 17.
4
New horizons for reduction of blood use: Patient blood management.减少血液使用的新视野：患者血液管理。
Asian J Transfus Sci. 2023 Jan-Jun;17(1):108-116. doi: 10.4103/ajts.ajts_14_21. Epub 2022 Dec 12.
5
Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020.血液透析中的血红蛋白与临床结局：对2018年至2020年美国医疗保险数据的分析
Kidney Med. 2022 Dec 7;5(2):100578. doi: 10.1016/j.xkme.2022.100578. eCollection 2023 Feb.
6
Current Practices and Guidelines for Perioperative Blood Management in Post-Bariatric Body Contouring Surgery: A Comprehensive Review of Literature.围手术期血液管理在减重后身体塑形手术中的应用现状和指南：文献综述。
Aesthetic Plast Surg. 2023 Aug;47(4):1462-1471. doi: 10.1007/s00266-022-03192-z. Epub 2022 Nov 28.
7
Effect of vitamin and mineral supplementation on nutritional status in children with chronic kidney disease: Protocol for a systematic review and meta-analysis.维生素和矿物质补充对慢性肾脏病儿童营养状况的影响：系统评价和荟萃分析方案。
Medicine (Baltimore). 2022 Oct 28;101(43):e31518. doi: 10.1097/MD.0000000000031518.
8
Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery.不同术前血液管理方案对老年延迟性股骨转子间骨折手术患者的临床应用效果。
Clin Interv Aging. 2022 May 20;17:825-835. doi: 10.2147/CIA.S362020. eCollection 2022.
9
Dynamics of Erythroferrone Response to Erythropoietin in Rats.大鼠中促红细胞生成素对促红细胞生成素铁蛋白的反应动力学
Front Pharmacol. 2022 Apr 20;13:876573. doi: 10.3389/fphar.2022.876573. eCollection 2022.
10
Roxadustat for CKD-related Anemia in Non-dialysis Patients.罗沙司他用于非透析患者的慢性肾脏病相关贫血
Kidney Int Rep. 2020 Dec 5;6(3):624-635. doi: 10.1016/j.ekir.2020.11.034. eCollection 2021 Mar.